Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 8 |
| 1.1 List of Tables | 7 | 2 |
| 1.2 List of Figures | 9 | 1 |
| 2 Introduction | 10 | 1 |
| 2.1 Clinical Chemistry Analyzers Overview | 10 | 1 |
| 3 Products under Development | 11 | 5 |
| 3.1 Clinical Chemistry Analyzers - Pipeline Products by Stage of Development | 11 | 1 |
| 3.2 Clinical Chemistry Analyzers - Pipeline Products by Segment | 12 | 1 |
| 3.3 Clinical Chemistry Analyzers - Pipeline Products by Territory | 13 | 1 |
| 3.4 Clinical Chemistry Analyzers - Pipeline Products by Regulatory Path | 14 | 1 |
| 3.5 Clinical Chemistry Analyzers - Pipeline Products by Estimated Approval Date | 15 | 1 |
| 4 Clinical Chemistry Analyzers - Pipeline Products under Development by Companies | 16 | 3 |
| 4.1 Clinical Chemistry Analyzers Companies - Pipeline Products by Stage of Development | 16 | 2 |
| 4.2 Clinical Chemistry Analyzers - Pipeline Products by Stage of Development | 18 | 1 |
| 5 Clinical Chemistry Analyzers Companies and Product Overview | 19 | 41 |
| 5.1 Analyticon Biotechnologies AG Company Overview | 19 | 1 |
| 5.1.1 Analyticon Biotechnologies AG Pipeline Products &Ongoing Clinical Trials Overview | 19 | 4 |
| 5.2 Ativa Medical Inc. Company Overview | 23 | 1 |
| 5.2.1 Ativa Medical Inc. Pipeline Products &Ongoing Clinical Trials Overview | 23 | 2 |
| 5.3 Aviv Biomedical, Inc. Company Overview | 25 | 1 |
| 5.3.1 Aviv Biomedical, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 25 | 1 |
| 5.4 Beacon Biotechnology Company Overview | 26 | 1 |
| 5.4.1 Beacon Biotechnology Pipeline Products &Ongoing Clinical Trials Overview | 26 | 1 |
| 5.5 Curetis N.V. Company Overview | 27 | 1 |
| 5.5.1 Curetis N.V. Pipeline Products &Ongoing Clinical Trials Overview | 27 | 2 |
| 5.6 Daxor Corporation Company Overview | 29 | 1 |
| 5.6.1 Daxor Corporation Pipeline Products &Ongoing Clinical Trials Overview | 29 | 1 |
| 5.7 DiaSys Diagnostic Systems GmbH Company Overview | 30 | 1 |
| 5.7.1 DiaSys Diagnostic Systems GmbH Pipeline Products &Ongoing Clinical Trials Overview | 30 | 2 |
| 5.8 EMERGENT DETECTION INC Company Overview | 32 | 1 |
| 5.8.1 EMERGENT DETECTION INC Pipeline Products &Ongoing Clinical Trials Overview | 32 | 1 |
| 5.9 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview | 33 | 1 |
| 5.9.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products &Ongoing Clinical Trials Overview | 33 | 2 |
| 5.10 Illumina, Inc. Company Overview | 35 | 1 |
| 5.10.1 Illumina, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 35 | 2 |
| 5.11 Intelligent Fingerprinting Ltd Company Overview | 37 | 1 |
| 5.11.1 Intelligent Fingerprinting Ltd Pipeline Products &Ongoing Clinical Trials Overview | 37 | 1 |
| 5.12 I-Sens Inc. Company Overview | 38 | 1 |
| 5.12.1 I-Sens Inc. Pipeline Products &Ongoing Clinical Trials Overview | 38 | 2 |
| 5.13 MyCartis NV Company Overview | 40 | 1 |
| 5.13.1 MyCartis NV Pipeline Products &Ongoing Clinical Trials Overview | 40 | 2 |
| 5.14 NanoIVD Inc (Inactive) Company Overview | 42 | 1 |
| 5.14.1 NanoIVD Inc (Inactive) Pipeline Products &Ongoing Clinical Trials Overview | 42 | 1 |
| 5.15 National Institute of Biomedical Imaging and Bioengineering Company Overview | 43 | 1 |
| 5.15.1 National Institute of Biomedical Imaging and Bioengineering Pipeline Products &Ongoing Clinical Trials Overview | 43 | 1 |
| 5.16 NeuMoDx Molecular, Inc Company Overview | 44 | 1 |
| 5.16.1 NeuMoDx Molecular, Inc Pipeline Products &Ongoing Clinical Trials Overview | 44 | 1 |
| 5.17 OPKO Health, Inc. Company Overview | 45 | 1 |
| 5.17.1 OPKO Health, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 45 | 2 |
| 5.18 OptiCul Diagnostics Ltd. Company Overview | 47 | 1 |
| 5.18.1 OptiCul Diagnostics Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 47 | 1 |
| 5.19 Renishaw Plc Company Overview | 48 | 1 |
| 5.19.1 Renishaw Plc Pipeline Products &Ongoing Clinical Trials Overview | 48 | 2 |
| 5.20 Rheonix, Inc. Company Overview | 50 | 1 |
| 5.20.1 Rheonix, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 50 | 1 |
| 5.21 Samsung Electronics Co., Ltd. Company Overview | 51 | 1 |
| 5.21.1 Samsung Electronics Co., Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 51 | 2 |
| 5.22 Sekisui Diagnostics, LLC. Company Overview | 53 | 1 |
| 5.22.1 Sekisui Diagnostics, LLC. Pipeline Products &Ongoing Clinical Trials Overview | 53 | 1 |
| 5.23 Smiths Detection Group Limited Company Overview | 54 | 1 |
| 5.23.1 Smiths Detection Group Limited Pipeline Products &Ongoing Clinical Trials Overview | 54 | 2 |
| 5.24 The Hong Kong University of Science and Technology Company Overview | 56 | 1 |
| 5.24.1 The Hong Kong University of Science and Technology Pipeline Products &Ongoing Clinical Trials Overview | 56 | 1 |
| 5.25 Theranos Inc Company Overview | 57 | 1 |
| 5.25.1 Theranos Inc Pipeline Products &Ongoing Clinical Trials Overview | 57 | 2 |
| 5.26 Thermal Gradient, Inc. Company Overview | 59 | 1 |
| 5.26.1 Thermal Gradient, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 59 | 1 |
| 6 Clinical Chemistry Analyzers- Recent Developments | 60 | 103 |
| 6.1 Nov 10, 2016: Siemens Healthcare Plans IPO | 60 | 1 |
| 6.2 Nov 08, 2016: Exact Sciences Appoints Jeff Elliott Chief Financial Officer | 60 | 1 |
| 6.3 Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results | 60 | 1 |
| 6.4 Nov 07, 2016: PerkinElmer Announces Financial Results for the Third Quarter of 2016 | 61 | 1 |
| 6.5 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results | 62 | 1 |
| 6.6 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance | 63 | 1 |
| 6.7 Nov 02, 2016: QIAGEN Reports Results for Third Quarter and First Nine Months of 2016 | 64 | 3 |
| 6.8 Nov 02, 2016: Lak Ananth to head new next47 startup unit | 67 | 1 |
| 6.9 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent | 68 | 1 |
| 6.10 Nov 01, 2016: Illumina Reports Full Financial Results for Third Quarter of Fiscal Year 2016 | 69 | 1 |
| 6.11 Nov 01, 2016: Asuragen Launches QuantideX NGS RNA Lung Cancer Kit | 70 | 1 |
| 6.12 Nov 01, 2016: IDEXX Laboratories Announces Third Quarter Results | 70 | 3 |
| 6.13 Nov 01, 2016: Introducing Renishaw's new RA802 Pharmaceutical Analyser | 73 | 1 |
| 6.14 Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance | 73 | 1 |
| 6.15 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results | 74 | 1 |
| 6.16 Oct 25, 2016: Abaxis Reports Financial Performance For The Second Quarter Of Fiscal 2017 | 75 | 2 |
| 6.17 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 | 77 | 2 |
| 6.18 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results | 79 | 3 |
| 6.19 Oct 19, 2016: IDEXX Laboratories Elects Lawrence D. Kingsley to Board of Directors | 82 | 1 |
| 6.20 Oct 18, 2016: Agenix: US sales and key appointment | 82 | 1 |
| 6.21 Oct 17, 2016: PerkinElmer Elects Samuel Chapin to Board of Directors | 82 | 1 |
| 6.22 Oct 17, 2016: Thermo Fisher Scientific Enables Preemptive Pharmacogenomic Screening Research with New PharmacoScan Solution | 83 | 1 |
| 6.23 Oct 17, 2016: New design of hematology and clinical chemistry analyzers | 84 | 1 |
| 6.24 Oct 14, 2016: Agenix: Appointment of Independent Non- Executive Directors | 84 | 1 |
| 6.25 Oct 12, 2016: Danaher to Acquire Phenomenex | 84 | 1 |
| 6.26 Oct 10, 2016: Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016 | 85 | 1 |
| 6.27 Oct 03, 2016: Boule Diagnostics Raises Funds in Private Placement of Shares | 85 | 1 |
| 6.28 Sep 26, 2016: PerkinElmer Announces New Organizational Structure | 85 | 1 |
| 6.29 Sep 24, 2016: Proxima Demonstrated at NVIC Congress Following Significant Sale in Benelux | 85 | 1 |
| 6.30 Sep 23, 2016: Siegfried Russwurm to resign by mutual agreement from the Siemens Management Board | 86 | 1 |
| 6.31 Sep 15, 2016: Unique in-line blood gas analyser selected to feature in BACCN annual conference Simulation Lab | 86 | 1 |
| 6.32 Sep 14, 2016: Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes | 87 | 1 |
| 6.33 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories | 87 | 1 |
| 6.34 Sep 12, 2016: Patient-dedicated blood gas analysis enhances flu readiness and infection control | 87 | 1 |
| 6.35 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report | 88 | 2 |
| 6.36 Sep 07, 2016: Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028 | 90 | 1 |
| 6.37 Sep 07, 2016: Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 | 91 | 1 |
| 6.38 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results | 92 | 1 |
| 6.39 Sep 02, 2016: Danaher Acquires Cepheid | 92 | 1 |
| 6.40 Aug 31, 2016: bioMerieux - First-Half 2016 Results | 93 | 3 |
| 6.41 Aug 30, 2016: Sphere Medical expands sales into Belgium | 96 | 1 |
| 6.42 Aug 30, 2016: AGENIX Announces Annual Result For The Year Ended 30 June 2016 | 97 | 1 |
| 6.43 Aug 19, 2016: Curetis Reports Financial Results for the First Six Months of 2016 | 98 | 2 |
| 6.44 Aug 18, 2016: Thermo Fisher Scientific May Acquire Illumina for USD30 Billion | 100 | 1 |
| 6.45 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results | 100 | 1 |
| 6.46 Aug 11, 2016: Akers Biosciences Announces H1 and Q2 2016 Earnings | 101 | 1 |
| 6.47 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results | 102 | 1 |
| 6.48 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results | 103 | 2 |
| 6.49 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter | 105 | 1 |
| 6.50 Aug 04, 2016: PerkinElmer Announces Financial Results for the Second Quarter of 2016 | 106 | 1 |
| 6.51 Aug 04, 2016: Diasorin Group Revenues And EBITDA Reached Record highs In the Second Quarter 2016 | 107 | 4 |
| 6.52 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results | 111 | 1 |
| 6.53 Jul 28, 2016: Illumina Names Philip W. Schiller to its Board of Directors | 112 | 1 |
| 6.54 Jul 28, 2016: Thermo Fisher Scientific Reports Second Quarter 2016 Results | 112 | 1 |
| 6.55 Jul 28, 2016: QIAGEN Reports Results for Second Quarter of 2016; Increased Commitment to Return $300 Million of Capital to Shareholders by End-2017 | 113 | 3 |
| 6.56 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors | 116 | 1 |
| 6.57 Jul 28, 2016: Luminex Reports Second Quarter 2016 Results | 116 | 1 |
| 6.58 Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results | 117 | 1 |
| 6.59 Jul 27, 2016: PerkinElmer Elects Frank Witney to Board of Directors | 118 | 1 |
| 6.60 Jul 26, 2016: Mindray and MedTest announce FDA 510(k) Clearance for the BA-800M Clinical Chemistry Analyzer | 118 | 1 |
| 6.61 Jul 26, 2016: Illumina Reports Financial Results for Second Quarter of Fiscal Year 2016 | 119 | 1 |
| 6.62 Jul 25, 2016: Abingdon Health announces GMP compliant facilities and registration with U.S. FDA | 120 | 1 |
| 6.63 Jul 21, 2016: Abaxis Reports Financial Performance for the First Quarter of Fiscal 2017 and Declares a Quarterly Cash Dividend | 120 | 2 |
| 6.64 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results | 122 | 2 |
| 6.65 Jul 19, 2016: MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts | 124 | 1 |
| 6.66 Jul 18, 2016: bioMerieux Second-Quarter 2016 Business Review | 125 | 3 |
| 6.67 Jul 14, 2016: microDimensions Raises Funds in Series A Financing Round | 128 | 1 |
| 6.68 Jul 12, 2016: PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026 | 128 | 1 |
| 6.69 Jul 11, 2016: Abingdon Health Raises USD4 Million in Venture Financing | 128 | 1 |
| 6.70 Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director | 129 | 1 |
| 6.71 Jul 07, 2016: Enzo Biochem s Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina | 129 | 1 |
| 6.72 Jul 06, 2016: Luminex Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System | 129 | 1 |
| 6.73 Jul 04, 2016: Exiqon Nomination of candidates for the supervisory board | 130 | 1 |
| 6.74 Jul 04, 2016: Curetis Appoints Christopher M. Bernard as Chief Executive Officer of Newly-Formed U.S. Subsidiary | 130 | 1 |
| 6.75 Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance | 131 | 1 |
| 6.76 Jun 17, 2016: Daxor Announces Hiring of Chief Financial Officer | 132 | 1 |
| 6.77 Jun 15, 2016: Siemens Healthcare Becomes Siemens Healthineers | 132 | 1 |
| 6.78 Jun 14, 2016: Proxima interface to Conworx data management solutions enables seamless data transfer from ex-vivo analyser | 132 | 1 |
| 6.79 Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market | 133 | 1 |
| 6.80 Jun 10, 2016: Diadexus to File Chapter 7 | 133 | 1 |
| 6.81 Jun 06, 2016: Curetis and Axonlab sign multi-market European distribution agreement | 134 | 1 |
| 6.82 Jun 02, 2016: EKF Diagnostics Raises USD7 Million in Private Placement of Shares | 134 | 1 |
| 6.83 Jun 02, 2016: Illumina Appoints Paula Dowdy Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa | 134 | 1 |
| 6.84 May 31, 2016: ERBA Diagnostics Announces Extension of CEO S Contract Term and Appointment of Hayden Jeffreys to Board of Directors | 135 | 1 |
| 6.85 May 20, 2016: ERBA Diagnostics Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan | 135 | 1 |
| 6.86 May 20, 2016: Curetis Publishes First Quarter 2016 Business and Financial Update | 136 | 1 |
| 6.87 May 12, 2016: Akers Biosciences: Financial Results for the First Quarter 2016 | 137 | 2 |
| 6.88 May 12, 2016: Akers Biosciences Reports Earnings for Q1 2016 | 139 | 3 |
| 6.89 May 12, 2016: Boule Diagnostics Interim report January-March 2016 | 142 | 1 |
| 6.90 May 11, 2016: Clarissa Haller new head of communications at Siemens | 143 | 1 |
| 6.91 May 10, 2016: Thermo Fisher Scientific Reports Progress on Global Corporate Social Responsibility | 143 | 1 |
| 6.92 May 09, 2016: EKF Diagnostics Announces Directorate Change | 144 | 1 |
| 6.93 May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results | 144 | 1 |
| 6.94 May 04, 2016: Earnings Release and Financial Results Q2 FY 2016: Continuing growth in orders, revenue and profitability | 145 | 1 |
| 6.95 Apr 20, 2016: Abbott Reports First-Quarter 2016 Results | 145 | 3 |
| 6.96 Apr 20, 2016: EKF Diagnostics Holdings Announces Directorate Change | 148 | 1 |
| 6.97 Apr 18, 2016: NanoIVD Announces 510(k) Pre-Sub Supplement on PanOnco Check | 148 | 1 |
| 6.98 Apr 12, 2016: EKF Diagnostics Holdings: Final results | 149 | 3 |
| 6.99 Apr 07, 2016: Luminex to Showcase CE-IVD Marked ARIES System, Revolutionary Software, and Assays at ECCMID Annual Meeting | 152 | 1 |
| 6.100 Mar 23, 2016: STRATEC Biomedical to Acquire Diatron from Riverside Company | 153 | 1 |
| 6.101 Mar 16, 2016: New Luna Omega 1.6 Micron Particle Brings Acclaimed Capabilities to UHPLC | 153 | 1 |
| 6.102 Mar 14, 2016: Instrumentation Laboratory Reports Record Worldwide Sales In 2015 | 154 | 1 |
| 6.103 Mar 01, 2016: HORIBA: Alliance'2016 | 155 | 1 |
| 6.104 Feb 23, 2016: Thermo Fisher Scientific Exhibits ClinQuan MD Software for In Vitro Diagnostic Use at MSACL 2016 | 155 | 1 |
| 6.105 Feb 18, 2016: Boule Diagnostics: Year-end report 2015 | 155 | 1 |
| 6.106 Feb 12, 2016: DiaSys Diagnostic Systems presents QDx Lipidcheck at Arab Health in January 2016 | 156 | 1 |
| 6.107 Feb 09, 2016: HORIBA Formulates New Mid-Long Term Management Plan MLMAP2020 | 157 | 1 |
| 6.108 Feb 02, 2016: Life Line Screening Enters Into Multi-Year Contract Extension for CardioChek Family of Lipid and Glucose Products | 158 | 1 |
| 6.109 Jan 29, 2016: IDEXX Laboratories Announces Fourth Quarter and Full Year 2015 Results | 158 | 2 |
| 6.110 Jan 26, 2016: Sphere Medical Holding: Contract Win | 160 | 1 |
| 6.111 Jan 26, 2016: Premaitha Health: Update on UK Litigation Timing | 161 | 1 |
| 6.112 Jan 20, 2016: EKF Diagnostics highlight new clinical chemistry analyzer at Arab Health 2016 | 161 | 1 |
| 6.113 Dec 03, 2015: Patient-dedicated blood gas analyser for use in winter flu isolation beds | 162 | 1 |
| 7 Appendix | 163 | 4 |
| 7.1 Methodology | 163 | 3 |
| 7.2 About GlobalData | 166 | 1 |
| 7.3 Contact Us | 166 | 1 |
| 7.4 Disclaimer | 166 | 1 |
